The store will not work correctly when cookies are disabled.
5-Chloro-N-(2,4-difluorobenzyl)-2-hydroxybenzamide
ID: ALA4550809
PubChem CID: 60739715
Max Phase: Preclinical
Molecular Formula: C14H10ClF2NO2
Molecular Weight: 297.69
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(NCc1ccc(F)cc1F)c1cc(Cl)ccc1O
Standard InChI: InChI=1S/C14H10ClF2NO2/c15-9-2-4-13(19)11(5-9)14(20)18-7-8-1-3-10(16)6-12(8)17/h1-6,19H,7H2,(H,18,20)
Standard InChI Key: RJIVIJGWTQDTLR-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
2.3263 -2.4350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3252 -3.2546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0332 -3.6635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7429 -3.2541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7401 -2.4314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0314 -2.0262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4462 -2.0202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1555 -2.4261 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8616 -2.0148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4432 -1.2030 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.0290 -1.2090 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.0330 -4.4807 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
6.5709 -2.4208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5709 -3.2368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2793 -3.6427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9864 -3.2314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9807 -2.4100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2717 -2.0078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2650 -1.1906 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8.6962 -3.6363 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
8 9 1 0
7 10 2 0
6 11 1 0
3 12 1 0
9 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
18 19 1 0
16 20 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 297.69 | Molecular Weight (Monoisotopic): 297.0368 | AlogP: 3.25 | #Rotatable Bonds: 3 |
Polar Surface Area: 49.33 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.66 | CX Basic pKa: ┄ | CX LogP: 4.01 | CX LogD: 3.82 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.91 | Np Likeness Score: -1.82 |
References
1. Xu J, Berastegui-Cabrera J, Chen H, Pachón J, Zhou J, Sánchez-Céspedes J.. (2020) Structure-Activity Relationship Studies on Diversified Salicylamide Derivatives as Potent Inhibitors of Human Adenovirus Infection., 63 (6): [PMID:32045239] [10.1021/acs.jmedchem.9b01950] |